会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Acyclovir diester derivatives
    • 阿昔洛韦二酯衍生物
    • US06214811B1
    • 2001-04-10
    • US09514552
    • 2000-02-28
    • Arnold GlazierMilka YanachkovaIvan Yanachkov
    • Arnold GlazierMilka YanachkovaIvan Yanachkov
    • A61K31675
    • C07F9/65616
    • Disclosed are novel prodrugs represented by the following structural formula; Z is oxygen or sulfur; Y is, together with a hydroxy group, acyclovir or an analog of acyclovir; A is a substituted benzyl group with one or more protected hydroxy or protected amine groups in the ortho or para positions, relative to the phosphate ester, which can be converted in vivo to a hydroxy or amino group. Also disclosed is a method of treating a viral infection in an individual or animal. The method comprises administering to the individual or animal a therapeutically effective amount of a prodrug represented by structural formula shown above.
    • 公开了由以下结构式表示的新型前药:Z是氧或硫; Y与羟基,阿昔洛韦或阿昔洛韦的类似物一起; A是相对于磷酸酯在邻位或对位具有一个或多个保护的羟基或被保护的胺基的取代苄基,其可在体内转化为羟基或氨基。 还公开了一种治疗个体或动物中的病毒感染的方法。 该方法包括向个体或动物施用治疗有效量的由上述结构式表示的前药。